Thursday, May 17, 2007

DUSA Receives Orphan Drug Status

DUSA Pharmaceuticals Inc. (DUSA) announced that it received orphan drug status for its esophageal cancer drug treatment sending the stock price soaring $1.99 to $4.76.

0 Comments:

Post a Comment

<< Home